One-Time Screening for Colorectal Cancer with Combined Fecal Occult-Blood Testing and Examination of the Distal Colon
David A. Lieberman, M.D., William V. Harford, M.D., Dennis J. Ahnen, M.D., Dawn Provenzale, M.D., Stephen J. Sontag, M.D., Thomas G. Schnell, M.D., Gregorio Chejfec, M.D., Donald R. Campbell, M.D., Theodore E. Durbin, M.D., John H. Bond, M.D., Douglas B. Nelson, M.D., Stephen L. Ewing, M.D., George Triadafilopoulos, M.D., Francisco C. Ramirez, M.D., John G. Lee, M.D., Judith F. Collins, M.D., M. Brian Fennerty, M.D., Tiina K. Johnston, R.N., Ed.M., Christopher L. Corless, M.D., Ph.D., Kenneth R. McQuaid, M.D., Harinder Garewal, M.D., Ph.D., Richard E. Sampliner, M.D., Thomas G. Morales, M.D., Ronnie Fass, M.D., Robert E. Smith, M.D., Yogesh Maheshwari, M.D., David G. Weiss, Ph.D., for the Veterans Affairs Cooperative Study Group 380
Background Fecal occult-blood testing and sigmoidoscopy havebeen recommended for screening for colorectal cancer, but thesensitivity of such combined testing for detecting neoplasiais uncertain. At 13 Veterans Affairs medical centers, we performedcolonoscopy to determine the prevalence of neoplasia and thesensitivity of one-time screening with a fecal occult-bloodtest plus sigmoidoscopy.
Methods Asymptomatic subjects (age range, 50 to 75 years) providedstool specimens on cards from three consecutive days for fecaloccult-blood testing, which were rehydrated for interpretation.They then underwent colonoscopy. Sigmoidoscopy was defined asexamination of the rectum and sigmoid colon during colonoscopy,and sensitivity was estimated by determining how many patientswith advanced neoplasia had an adenoma in the rectum or sigmoidcolon. Advanced colonic neoplasia was defined as an adenoma10 mm or more in diameter, a villous adenoma, an adenoma withhigh-grade dysplasia, or invasive cancer.
Results A total of 2885 subjects returned the three specimencards for fecal occult-blood testing and underwent a completecolonoscopic examination. A total of 23.9 percent of subjectswith advanced neoplasia had a positive test for fecal occultblood. As compared with subjects who had a negative test forfecal occult blood, the relative risk of advanced neoplasiain subjects who had a positive test was 3.47 (95 percent confidenceinterval, 2.76 to 4.35). Sigmoidoscopy identified 70.3 percentof all subjects with advanced neoplasia. Combined one-time screeningwith a fecal occult-blood test and sigmoidoscopy identified75.8 percent of subjects with advanced neoplasia.
Conclusions One-time screening with both a fecal occult-bloodtest with rehydration and sigmoidoscopy fails to detect advancedcolonic neoplasia in 24 percent of subjects with the condition.
Source Information
From the Veterans Affairs medical centers in Portland, Oreg. (D.A.L.), and Perry Point, Md. (D.G.W.).
Other authors from Veterans Affairs medical centers were William V. Harford, M.D., Dallas; Dennis J. Ahnen, M.D., Denver; Dawn Provenzale, M.D., Durham, N.C.; Stephen J. Sontag, M.D., Thomas G. Schnell, M.D., and Gregorio Chejfec, M.D., Hines, Ill.; Donald R. Campbell, M.D., Kansas City, Mo.; Theodore E. Durbin, M.D., Long Beach, Calif.; John H. Bond, M.D., Douglas B. Nelson, M.D., and Stephen L. Ewing, M.D., Minneapolis; George Triadafilopoulos, M.D., Palo Alto, Calif.; Francisco C. Ramirez, M.D., Phoenix, Ariz.; John G. Lee, M.D., Judith F. Collins, M.D., M. Brian Fennerty, M.D., Tiina K. Johnston, R.N., Ed.M., and Christopher L. Corless, M.D., Ph.D., Portland, Oreg.; Kenneth R. McQuaid, M.D., San Francisco; Harinder Garewal, M.D., Ph.D., Richard E. Sampliner, M.D., Thomas G. Morales, M.D., and Ronnie Fass, M.D., Tucson, Ariz.; and Robert E. Smith, M.D., and Yogesh Maheshwari, M.D., White River Junction, Vt.
Address reprint requests to Dr. Lieberman at the Division of Gastroenterology, Oregon Health Sciences University, Portland Veterans Affairs Medical Center P3-GI, P.O. Box 1034, Portland, OR 97207, or at lieberma{at}ohsu.edu.
Subramanian, S., Bobashev, G., Morris, R. J.
(2009). Modeling the Cost-Effectiveness of Colorectal Cancer Screening: Policy Guidance Based on Patient Preferences and Compliance. Cancer Epidemiol. Biomarkers Prev.
18: 1971-1978
[Abstract][Full Text]
Hoff, G., Grotmol, T., Skovlund, E., Bretthauer, M., for the Norwegian Colorectal Cancer Prevention Stu,
(2009). Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised controlled trial. BMJ
338: b1846-b1846
[Abstract][Full Text]
Hundt, S., Haug, U., Brenner, H.
(2009). Comparative Evaluation of Immunochemical Fecal Occult Blood Tests for Colorectal Adenoma Detection. ANN INTERN MED
150: 162-169
[Abstract][Full Text]
Graser, A, Stieber, P, Nagel, D, Schafer, C, Horst, D, Becker, C R, Nikolaou, K, Lottes, A, Geisbusch, S, Kramer, H, Wagner, A C, Diepolder, H, Schirra, J, Roth, H J, Seidel, D, Goke, B, Reiser, M F, Kolligs, F T
(2009). Comparison of CT colonography, colonoscopy, sigmoidoscopy and faecal occult blood tests for the detection of advanced adenoma in an average risk population. Gut
58: 241-248
[Abstract][Full Text]
Baxter, N. N., Goldwasser, M. A., Paszat, L. F., Saskin, R., Urbach, D. R., Rabeneck, L.
(2009). Association of Colonoscopy and Death From Colorectal Cancer. ANN INTERN MED
150: 1-8
[Abstract][Full Text]
Koga, Y., Yasunaga, M., Moriya, Y., Akasu, T., Fujita, S., Yamamoto, S., Baba, H., Matsumura, Y.
(2009). Detection of the DNA Point Mutation of Colorectal Cancer Cells Isolated from Feces Stored Under Different Conditions. Jpn J Clin Oncol
39: 62-69
[Abstract][Full Text]
Ahlquist, D. A., Sargent, D. J., Loprinzi, C. L., Levin, T. R., Rex, D. K., Ahnen, D. J., Knigge, K., Lance, M. P., Burgart, L. J., Hamilton, S. R., Allison, J. E., Lawson, M. J., Devens, M. E., Harrington, J. J., Hillman, S. L.
(2008). Stool DNA and Occult Blood Testing for Screen Detection of Colorectal Neoplasia. ANN INTERN MED
149: 441-450
[Abstract][Full Text]
Chung, D. C.
(2008). Stool DNA Testing and Colon Cancer Prevention: Another Step Forward. ANN INTERN MED
149: 509-510
[Full Text]
Lance, P.
(2008). Colorectal Cancer Screening: Confusion Reigns. Cancer Epidemiol. Biomarkers Prev.
17: 2205-2207
[Full Text]
BIANCHI, L. K., BURKE, C. A.
(2008). Understanding current guidelines for colorectal cancer screening: A case-based approach. Cleveland Clinic Journal of Medicine
75: 441-448
[Abstract][Full Text]
Levin, B., Lieberman, D. A., McFarland, B., Smith, R. A., Brooks, D., Andrews, K. S., Dash, C., Giardiello, F. M., Glick, S., Levin, T. R., Pickhardt, P., Rex, D. K., Thorson, A., Winawer, S. J., for the American Cancer Society Colorectal Cancer,
(2008). Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous Polyps, 2008: A Joint Guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin
58: 130-160
[Abstract][Full Text]
Smith, R. A., Cokkinides, V., Brawley, O. W.
(2008). Cancer Screening in the United States, 2008: A Review of Current American Cancer Society Guidelines and Cancer Screening Issues. CA Cancer J Clin
58: 161-179
[Abstract][Full Text]
Iglar, K., Katyal, S., Matthew, R., Dubey, V.
(2008). Complete health checkup for adults: Update on the Preventive Care Checklist Form(C). cfp
54: 84-88
[Full Text]
Brenner, H., Hoffmeister, M., Stegmaier, C., Brenner, G., Altenhofen, L., Haug, U.
(2007). Risk of progression of advanced adenomas to colorectal cancer by age and sex: estimates based on 840 149 screening colonoscopies. Gut
56: 1585-1589
[Abstract][Full Text]
Saar, B, Meining, A, Beer, A, Settles, M, Helmberger, H, Frimberger, E, Rummeny, E J, Rosch, T
(2007). Prospective study on bright lumen magnetic resonance colonography in comparison with conventional colonoscopy. Br. J. Radiol.
80: 235-241
[Abstract][Full Text]
Sarfaty, M.
(2007). Quality in the Delivery of Preventive Services: The National Colorectal Cancer Roundtable. American Journal of Medical Quality
22: 127-132
Smith, R. A., Cokkinides, V., Eyre, H. J.
(2007). Cancer Screening in the United States, 2007: A Review of Current Guidelines, Practices, and Prospects. CA Cancer J Clin
57: 90-104
[Abstract][Full Text]
Brenner, H., Chang-Claude, J., Seiler, C. M., Sturmer, T., Hoffmeister, M.
(2007). Potential for Colorectal Cancer Prevention of Sigmoidoscopy Versus Colonoscopy: Population-Based Case Control Study. Cancer Epidemiol. Biomarkers Prev.
16: 494-499
[Abstract][Full Text]
Lieberman, D.
(2006). A Call to Action -- Measuring the Quality of Colonoscopy. NEJM
355: 2588-2589
[Full Text]
Regula, J., Rupinski, M., Kraszewska, E., Polkowski, M., Pachlewski, J., Orlowska, J., Nowacki, M. P., Butruk, E.
(2006). Colonoscopy in Colorectal-Cancer Screening for Detection of Advanced Neoplasia. NEJM
355: 1863-1872
[Abstract][Full Text]
Bleiberg, H., Autier, P., Huet, F., Schrauwen, A. M., Staquet, E., Delaunoit, T., Hendlisz, A., Wyns, C., Panzer, J. M., Caucheteur, B., Eisendrath, P., Grivegnee, A.
(2006). Colorectal cancer (CRC) screening using sigmoidoscopy followed by colonoscopy: a feasibility and efficacy study on a cancer institute based population. Ann Oncol
17: 1328-1332
[Abstract][Full Text]
Knight, C. L., Fihn, S. D.
(2006). Update in General Internal Medicine. ANN INTERN MED
145: 52-61
[Full Text]
Singh, H., Turner, D., Xue, L., Targownik, L. E., Bernstein, C. N.
(2006). Risk of developing colorectal cancer following a negative colonoscopy examination: evidence for a 10-year interval between colonoscopies.. JAMA
295: 2366-2373
[Abstract][Full Text]
Church, T. R.
(2006). Screening for colorectal cancer by colonoscopy: adding to the evidence.. JAMA
295: 2411-2412
[Full Text]
Smith, R. A., Cokkinides, V., Eyre, H. J.
(2006). American Cancer Society Guidelines for the Early Detection of Cancer, 2006. CA Cancer J Clin
56: 11-25
[Abstract][Full Text]
Macari, M., Bini, E. J.
(2005). CT Colonography: Where Have We Been and Where Are We Going?. Radiology
237: 819-833
[Abstract][Full Text]
Weihrauch, M. R., Ansen, S., Jurkiewicz, E., Geisen, C., Xia, Z., Anderson, K. S., Gracien, E., Schmidt, M., Wittig, B., Diehl, V., Wolf, J., Bohlen, H., Nadler, L. M.
(2005). Phase I/II Combined Chemoimmunotherapy with Carcinoembryonic Antigen-Derived HLA-A2-Restricted CAP-1 Peptide and Irinotecan, 5-Fluorouracil, and Leucovorin in Patients with Primary Metastatic Colorectal Cancer. Clin. Cancer Res.
11: 5993-6001
[Abstract][Full Text]
Schoenfeld, P., Cash, B., Flood, A., Dobhan, R., Eastone, J., Coyle, W., Kikendall, J. W., Kim, H. M., Weiss, D. G., Emory, T., Schatzkin, A., Lieberman, D., the CONCeRN Study Investigators,
(2005). Colonoscopic Screening of Average-Risk Women for Colorectal Neoplasia. NEJM
352: 2061-2068
[Abstract][Full Text]
Segnan, N., Senore, C., Andreoni, B., Arrigoni, A., Bisanti, L., Cardelli, A., Castiglione, G., Crosta, C., DiPlacido, R., Ferrari, A., Ferraris, R., Ferrero, F., Fracchia, M., Gasperoni, S., Malfitana, G., Recchia, S., Risio, M., Rizzetto, M., Saracco, G., Spandre, M., Turco, D., Turco, P., Zappa, M., SCORE2 Working Group-Italy,
(2005). Randomized Trial of Different Screening Strategies for Colorectal Cancer: Patient Response and Detection Rates. JNCI J Natl Cancer Inst
97: 347-357
[Abstract][Full Text]
Yoong, K K Y, Heymann, T
(2005). Colonoscopy in the very old: why bother?. Postgrad. Med. J.
81: 196-197
[Abstract][Full Text]
Collins, J. F., Lieberman, D. A., Durbin, T. E., Weiss, D. G., and the Veterans Affairs Cooperative Study #380 Gr,
(2005). Accuracy of Screening for Fecal Occult Blood on a Single Stool Sample Obtained by Digital Rectal Examination: A Comparison with Recommended Sampling Practice. ANN INTERN MED
142: 81-85
[Abstract][Full Text]
Nadel, M. R., Shapiro, J. A., Klabunde, C. N., Seeff, L. C., Uhler, R., Smith, R. A., Ransohoff, D. F.
(2005). A National Survey of Primary Care Physicians' Methods for Screening for Fecal Occult Blood. ANN INTERN MED
142: 86-94
[Abstract][Full Text]
Imperiale, T. F., Ransohoff, D. F., Itzkowitz, S. H., Turnbull, B. A., Ross, M. E., the Colorectal Cancer Study Group,
(2004). Fecal DNA versus Fecal Occult Blood for Colorectal-Cancer Screening in an Average-Risk Population. NEJM
351: 2704-2714
[Abstract][Full Text]
van Gelder, R. E., Birnie, E., Florie, J., Schutter, M. P., Bartelsman, J. F., Snel, P., Lameris, J. S., Bonsel, G. J., Stoker, J.
(2004). CT Colonography and Colonoscopy: Assessment of Patient Preference in a 5-week Follow-up Study. Radiology
233: 328-337
[Abstract][Full Text]
Chao, A., Connell, C. J., Cokkinides, V., Jacobs, E. J., Calle, E. E., Thun, M. J.
(2004). Underuse of Screening Sigmoidoscopy and Colonoscopy in a Large Cohort of US Adults. Am. J. Public Health
94: 1775-1781
[Abstract][Full Text]
Rockey, D. C., Zarchy, T. M., Pais, S., Uribe, J. R., Bongiorno, C., Katz, P. O., Thomas, G. S., Pickhardt, P. J.
(2004). Virtual Colonoscopy to Screen for Colorectal Cancer. NEJM
350: 1148-1150
[Full Text]
Takahashi, P. Y., Okhravi, H. R., Lim, L. S., Kasten, M. J.
(2004). Preventive Health Care in the Elderly Population: A Guide for Practicing Physicians. Mayo Clin Proc.
79: 416-427
[Abstract]
Macari, M., Bini, E. J., Jacobs, S. L., Naik, S., Lui, Y. W., Milano, A., Rajapaksa, R., Megibow, A. J., Babb, J.
(2004). Colorectal Polyps and Cancers in Asymptomatic Average-Risk Patients: Evaluation with CT Colonography. Radiology
230: 629-636
[Abstract][Full Text]
Poullis, A., Foster, R., Shetty, A., Fagerhol, M. K., Mendall, M. A.
(2004). Bowel Inflammation as Measured by Fecal Calprotectin: A Link between Lifestyle Factors and Colorectal Cancer Risk. Cancer Epidemiol. Biomarkers Prev.
13: 279-284
[Abstract][Full Text]
Hawley, S. T., Vernon, S. W., Levin, B., Vallejo, B.
(2004). Prevalence of Colorectal Cancer Screening in a Large Medical Organization. Cancer Epidemiol. Biomarkers Prev.
13: 314-319
[Abstract][Full Text]
Schoen, R. E., Weissfeld, J. L.
(2003). Optimal Intervals and Techniques for Screening Sigmoidoscopy--Reply. JAMA
290: 2123-2123
[Full Text]
Lembo, A., Camilleri, M.
(2003). Chronic Constipation. NEJM
349: 1360-1368
[Full Text]
Strul, H., Barenboim, E., Leshno, M., Gartner, M., Kariv, R., Aljadeff, E., Aljadeff, Y., Kazanov, D., Strier, L., Keidar, A., Knaani, Y., Degani, Y., Alon-Baron, L., Sobol-Dvory, H., Halpern, Z., Arber, N.
(2003). The I1307K Adenomatous Polyposis Coli Gene Variant Does Not Contribute in the Assessment of the Risk for Colorectal Cancer in Ashkenazi Jews. Cancer Epidemiol. Biomarkers Prev.
12: 1012-1015
[Abstract][Full Text]
Rabeneck, L., Paszat, L. F.
(2003). Colorectal cancer screening in Canada: Why not consider nurse endoscopists?. CMAJ
169: 206-207
[Full Text]
Boynton, K. A., Summerhayes, I. C., Ahlquist, D. A., Shuber, A. P.
(2003). DNA Integrity as a Potential Marker for Stool-based Detection of Colorectal Cancer. Clin. Chem.
49: 1058-1065
[Abstract][Full Text]
Walsh, J. M. E., Terdiman, J. P.
(2003). Colorectal Cancer Screening: Scientific Review. JAMA
289: 1288-1296
[Abstract][Full Text]
Walsh, J. M. E., Terdiman, J. P.
(2003). Colorectal Cancer Screening: Clinical Applications. JAMA
289: 1297-1302
[Abstract][Full Text]
Watson, A J M
(2003). Are proximal colorectal cancers always associated with distal adenomas?. Gut
52: 317-318
[Full Text]
Gondal, G, Grotmol, T, Hofstad, B, Bretthauer, M, Eide, T J, Hoff, G
(2003). Grading of distal colorectal adenomas as predictors for proximal colonic neoplasia and choice of endoscope in population screening: experience from the Norwegian Colorectal Cancer Prevention study (NORCCAP). Gut
52: 398-403
[Abstract][Full Text]
Kirkpatrick, D. M.
(2003). Screening for Colorectal Cancer. ANN INTERN MED
138: 356-356
[Full Text]
Ayus, J C., Levine, R., Arieff, A. I
(2003). Lesson of the week: Fatal dysnatraemia caused by elective colonoscopy. BMJ
326: 382-384
[Full Text]
Gatto, N. M., Frucht, H., Sundararajan, V., Jacobson, J. S., Grann, V. R., Neugut, A. I.
(2003). Risk of Perforation After Colonoscopy and Sigmoidoscopy: A Population-Based Study. JNCI J Natl Cancer Inst
95: 230-236
[Abstract][Full Text]
Greenberger, N. J.
(2003). Update in Gastroenterology. ANN INTERN MED
138: 45-53
[Full Text]
Moayyedi, P., Ford, A.
(2002). Recent developments in gastroenterology. BMJ
325: 1399-1402
[Full Text]
Weihrauch, M. R., Skibowski, E., Koslowsky, T. C., Voiss, W., Re, D., Kuhn-Regnier, F., Bannwarth, C., Siedek, M., Diehl, V., Bohlen, H.
(2002). Immunomagnetic Enrichment and Detection of Micrometastases in Colorectal Cancer: Correlation With Established Clinical Parameters. JCO
20: 4338-4343
[Abstract][Full Text]
Swaroop, V. S., Larson, M. V.
(2002). Colonoscopy as a Screening Test for Colorectal Cancer in Average-Risk Individuals. Mayo Clin Proc.
77: 951-956
[Abstract]
Anderson, W. F., Guyton, K. Z., Hiatt, R. A., Vernon, S. W., Levin, B., Hawk, E.
(2002). Colorectal Cancer Screening for Persons at Average Risk. JNCI J Natl Cancer Inst
94: 1126-1133
[Full Text]
Brant-Zawadzki, M.
(2002). CT Screening: Why I Do It. Am. J. Roentgenol.
179: 319-326
[Full Text]
Pignone, M., Saha, S., Hoerger, T., Mandelblatt, J.
(2002). Cost-Effectiveness Analyses of Colorectal Cancer Screening: A Systematic Review for the U.S. Preventive Services Task Force. ANN INTERN MED
137: 96-104
[Abstract][Full Text]
Westcott, E D A, Windsor, A C J
(2002). Can we improve the outcome of colorectal cancer by early diagnosis?. Postgrad. Med. J.
78: 255-256
[Full Text]
Friedenberg, R. M.
(2002). The 21st Century: The Age of Screening. Radiology
223: 1-4
[Full Text]
Boyle, P.
(2002). Faecal occult blood testing (FOBT) as screening for colorectal cancer: the current controversy. Ann Oncol
13: 16-18
[Full Text]
Strul, H., Arber, N.
(2002). Fecal occult blood test for colorectal cancer screening. Ann Oncol
13: 51-56
[Full Text]
Ransohoff, D. F., Sandler, R. S.
(2002). Screening for Colorectal Cancer. NEJM
346: 40-44
[Full Text]
Smith, R. A., Cokkinides, V., von Eschenbach, A. C., Levin, B., Cohen, C., Runowicz, C. D., Sener, S., Saslow, D., Eyre, H. J.
(2002). American Cancer Society Guidelines for the Early Detection of Cancer. CA Cancer J Clin
52: 8-22
[Abstract][Full Text]
Allison, J. E., Selby, J., Launoy, G., Atlas, S. A., Finkelstein, C., Goss, J. R., Church, C. F., Greenberg, M. J., Wendt, E., Lieberman, D., Detsky, A. S.
(2001). Screening for Colorectal Cancer. NEJM
345: 1850-1852
[Full Text]
(2001). Primary care -- the hard parts. CMAJ
165: 1181-1181
[Full Text]